Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

医学 哮喘 特应性皮炎 人口 儿科 过敏 中耳炎 鼻塞 共病 皮肤病科 食物过敏 观察研究 鼻窦炎 内科学 鼻子 外科 免疫学 环境卫生
作者
María Dolores Ibáñez,Antonio Valero,Javier Montoro,Ignacio Jauregui,Marta Ferrer,Ignacio J. Davila,Joan Bartra,A del Cuvillo,Joaquim Mullol,Joaquin Sastre
出处
期刊:Pediatric Allergy and Immunology [Wiley]
卷期号:24 (7): 678-684 被引量:53
标识
DOI:10.1111/pai.12126
摘要

BACKGROUND: Allergic rhinitis (AR) is the most common chronic disease in children. The main objective of this study was to analyze the comorbidities and therapeutic approaches for AR in a Spanish pediatric population. METHODS: Children aged 6 to 12 years with AR were included in an observational, cross-sectional, multicenter study. RESULTS: 1,275 children were recruited from 271 centers. AR was intermittent in 59.5% of cases, persistent in 40.5%, seasonal in 60.7%, and perennial in 39.3% of patients. The most frequent comorbidities were conjunctivitis (53.6%), asthma (49.5%), atopic dermatitis (40%), rhinosinusitis(26.1%), otitis media (23.8%), and adenoid hypertrophy (17.3%). Overall, patients with persistent, moderate or severe, AR were more likely to present comobidities, except for food allergy and urticaria. The most common drugs used for treatment of AR were oral antihistamines(76%), nasal corticosteroids(49%) and a combination of both (45%). Antihistamines and nasal corticosteroids were used on demand (<18 days) in 38 and 41% of patients, respectively; for 18-30 days in 22 and 27%; for 1-3 months in 31 and 29%; and for more than 3 months in 8 and 3%, respectively. Eye drops were used in 32% and specific immunotherapy in 21% of patients. CONCLUSION: Comorbidities are frequent in children with AR, supporting the notion of allergy as a systemic disease. Severity and duration of AR were significantly associated with presence of most of comorbidities. The most common drugs used for AR treatment were oral antihistamines, followed by nasal corticosteroids and a combination of both used on demand.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小马甲的应助被科研通管家采纳,获得10
刚刚
脑洞疼的应助被科研通管家采纳,获得10
刚刚
NexusExplorer的应助被科研通管家采纳,获得10
刚刚
所所的应助被科研通管家采纳,获得10
刚刚
共享精神的应助被科研通管家采纳,获得10
刚刚
Jasper的应助被科研通管家采纳,获得10
刚刚
研友_VZG7GZ的应助被科研通管家采纳,获得10
刚刚
汉堡包的应助被科研通管家采纳,获得10
1秒前
Ava的应助被科研通管家采纳,获得10
1秒前
Ava的应助被MYY采纳,获得10
1秒前
充电宝的应助被科研通管家采纳,获得10
1秒前
852的应助被科研通管家采纳,获得10
1秒前
Owen的应助被白术子采纳,获得10
1秒前
大模型的应助被科研通管家采纳,获得10
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
852的应助被科研通管家采纳,获得10
1秒前
sean完成签到,获得积分10
2秒前
脑洞疼的应助被科研通管家采纳,获得10
2秒前
所所的应助被科研通管家采纳,获得10
2秒前
wg发布了新的文献求助10
2秒前
2秒前
Ava的应助被科研通管家采纳,获得10
2秒前
烟花的应助被科研通管家采纳,获得10
2秒前
CodeCraft的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
斯文败类的应助被科研通管家采纳,获得10
3秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
3秒前
深情安青的应助被科研通管家采纳,获得10
3秒前
今后的应助被科研通管家采纳,获得10
3秒前
3秒前
情怀的应助被科研通管家采纳,获得10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
ccnwu发布了新的文献求助10
3秒前
隐形曼青的应助被科研通管家采纳,获得10
3秒前
lh完成签到 ,获得积分10
3秒前
所所的应助被科研通管家采纳,获得10
3秒前
orixero的应助被科研通管家采纳,获得10
4秒前
十二月完成签到 ,获得积分10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165180
求助须知:如何正确求助?哪些是违规求助? 9558882
关于积分的说明 21747664
捐赠科研通 7755742
什么是DOI,文献DOI怎么找? 3428852
关于科研通互助平台的介绍 2553184
邀请新用户注册赠送积分活动 2473404